Foresight’s technology will be integrated into Natera’s Signatera platform and is expected to be launched for clinical use in 2026.
Natera acquires Foresight Diagnostics for up to $450M
Foresight’s technology will be integrated into Natera’s Signatera platform and is expected to be launched for clinical use in 2026.